FDA hosted its fourth summit on June 8, 2023, as an integral part of FDA’s overall efforts to protect the public, including youth, from harm associated with drugs that have abuse potential.
Similar Posts
Drug Trials Snapshots: HERNEXEOS
Drug Trials Snapshots: HERNEXEOSEarly Alert: Dialysis Tubing Set Issue from Vantive
Prismaflex Set deaeration chambers may dislodge from the Prismaflex Control Unit during use.Risk of False Positive Lead Test Results with Certain Capillary Blood Collection Tubes Used with Magellan Diagnostics LeadCare Testing Systems – FDA Safety Communication
FDA is alerting health care providers and lab staff of reports of false positives when using certain Micro Capillary Blood Collection tubes with the LeadCare Testing Systems.Guangdong Renhe Guozhuang Biotechnology Co., Ltd. – 719045 – 12/16/2025
CGMP/Finished Pharmaceuticals/AdulteratedDemers Food Group Voluntarily Recalls Select Scott & Jon’s Shrimp Scampi with Linguini Bowls Due to an Ingredient Recall Initiated by Nate’s Fine Foods for Possible Listeria Monocytogenes Contamination
Following a recall initiated by Nate’s Fine Foods of Roseville, CA, Demers Food Group has voluntarily recalled select Scott & Jon’s Shrimp Scampi with Linguini due to possible Listeria monocytogenes contamination. The voluntary recall was initiated because these products contain a recalled linguiniDrug Trials Snapshots
Drug Trials Snapshots: breaking down the what, how and why. Drug Trials Snapshots is part of an overall FDA effort to make demographic data more available and transparent.